Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-26 @ 1:43 AM
Study NCT ID:
NCT00065533
Status:
COMPLETED
Last Update Posted:
2007-06-22
First Post:
2003-07-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-07-28
First Submit QC Date:
None
Study First Post Date:
2003-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-06-21
Last Update Post Date:
2007-06-22
Last Update Post Date Type:
ESTIMATED